News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IsoTis OrthoBiologics Announces Final Resolution Of AFM Matter



9/15/2006 11:01:32 AM

LAUSANNE, SWITZERLAND, and IRVINE, CA, Sept. 15 /CNW/ - IsoTis S.A. (SWX/Euronext: ISON; TSX: ISO), the orthobiologics company, today announced that the amount of the fine for the timing of regulatory filings to the AFM regarding the merger of IsoTis N.V. and IsoTis S.A. (at that time named Modex Therapeutics S.A.) in 2002 has been set by the administrative Court of Appeal in the Netherlands at EUR 326,715 for IsoTis N.V. and IsoTis S.A. As previously reported, the Company recorded a provision for the total amount of the potential liability, EUR 653,430 (EUR 326,715 for each company).

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES